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Abstract  
Colorectal cancer rates in Latin American countries are less than half of those observed in the 
United States. Latin-Americans are the resultant of generations of admixture of Native 
American, European, and African individuals. The potential role of genetic admixture in 
colorectal carcinogenesis has not been examined. We evaluate the association of genetic 
ancestry with colorectal neoplasms in 190 adenocarcinomas, 113 sporadic adenomas and 243 
age-sex matched controls enrolled in a multicentric case-control study in Colombia. 
Individual ancestral genetic fractions were estimated using the STRUCTURE software, based 
on allele frequencies and assuming three distinct population origins. We used the Illumina 
Cancer Panel to genotype 1,421 sparse SNPs, and CEU, LWJ and CHB populations from the 
HapMap project as references. A total of 678 autosomal SNPs overlapped with the HapMap 
datasets SNPs and were used for ancestry estimations. African mean ancestry fraction was 
higher in adenomas (0.13, CI95% 0.11-0.15) and cancer cases (0.14, CI95% 0.12-0.16) 
compared to controls (0.11, CI95% 0.10-0.12). Conditional logistic regression analysis, 
controlling for known risk factors, showed a positive association of African ancestry per 10% 
increase with both colorectal adenoma (Odds Ratio: 1.12 CI95% 0.97-1.30) and  
adenocarcinoma (Odds Ratio: 1.19 CI95% 1.05-1.35). In conclusion, increased African 
ancestry (or variants linked to it) contributes to the increased susceptibility of colorectal 
cancer in admixed Latin American population. 
 
Keywords: colorectal neoplasm, Pedigree, Polymorphism, Genetic, Latin America, 
Colombia 
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Introduction  
Colorectal cancer incidence in Latin-America has steadily increased during the last decades1, 
however these rates are less than half of those observed in African Americans and Caucasian 
Americans in North America2. Colorectal cancer incidence rates largely vary across 
continents, showing the highest rates in those countries with mainly Caucasian populations1. 
Such differences, and even the recent rising trends observed in developing countries, have 
been attributed to the high and increasing prevalence of risk factors associated with a 
“westernized” lifestyle, such as obesity and physical inactivity3. The reasons behind the 
higher colorectal cancer risk among African Americans compared to non-Hispanic Whites 
(Caucasians) in the United States are still not clear. Several studies propose health disparities 
as the main reason behind these differences4,5. However, prospective evidence showed  that 
such factors explain roughly 27% of the excess risk in, African Americans relative to 
Whites6, suggests that variation in genetic susceptibility across populations may play an 
important role7,8. 
The observed increase in colorectal cancer incidence has possibly been accompanied, if not 
led, by an increase in the incidence of colorectal adenomas9,10. Adenomas are the main 
precursor lesions to most sporadic colorectal cancers and develop through the complex 
interactions of environmental and genetic risk factors11. Although recent reports have 
suggested that the risk of colorectal adenoma may be influenced by racial differences12,13 in 
admixed populations, these findings are based on reported ethnicity rather than measured 
genetic ancestry. Self-reported measures of ethnicity in admixed populations are notoriously 
inaccurate regarding the individual ancestry14. This is especially important in populations of 
Latin-America where the admixture between people of at least three continents (Africa, 
Europe and America) has been widespread since the 17th century.   
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In this study we used a sparse set of Single Nucleotide Polymorphisms (SNPs) to evaluate the 
association of genetic ancestry with the risk of colorectal adenomas and adenocarcinomas in 
the Colombian population controlling for well known colorectal cancer and adenoma risk 
factors.  
Material and methods 
Study population and enrolment  
Cases and controls were randomly extracted from a larger multi-center case-control study 
aimed at identifying the environmental and genetic risk factors of colorectal cancer in 
Colombia. After ethical approval from the ethics Board of The National Cancer Institute of 
Colombia, we recruited incident cases (diagnosed at enrolment) of colorectal adenoma and 
adenocarcinomas at major colonoscopy medical centers in six of the largest Colombian cities 
(Barranquilla, Bogota, Bucaramanga, Cali, Cartagena and Santa Marta) from January 2008 to 
February 2011. Colombia has not yet established a colorectal cancer screening program; 
therefore, most of the colonoscopy examinations were medically indicated. Cases were 
originally diagnosed after a complete and satisfactory colonoscopy examination, but only 
pathologically confirmed cases were finally enrolled in the study. Eligible cases were 
Colombians, residents in the city of enrollment, aged between 30 and 75 years at the time of 
colonoscopy, willing and mentally capable to participate, and did not have any personal 
history of colorectal cancer, ulcerative colitis or Crohn’s disease. Controls were approached 
at the waiting room of primary care units, nearby or in the same hospital where the cases 
were recruited among individuals attending for medical conditions different from 
gastrointestinal discomfort and willing to participate; they were unrelated to cases and had no 
personal history of cancer or colorectal adenomas. Controls were matched by sex and age 
group (± 5 years) to the cases.   
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Participants gave written informed consent, donated a blood sample and answered a full 
epidemiological survey, a food frequency questionnaire (FFQ) designed for the study15 and 
the short version of the IPAQ16 (International Physic Activity Questionnaire), looking into 
the best known risk factors for colorectal adenoma and adenocarcinoma 17.  Buffy coats were 
kept in portable liquid nitrogen containers until transferred in dry ice to the National Cancer 
Institute Facilities in Bogotá for final storage at -80°C. Questionnaires were processed 
centrally. We used Teleform™, version 5.2 software package (Cardiff Software, Inc.) to 
increase the efficiency of data management and reduce typing error. By the end of the 
recruitment phase, we enrolled 506 controls, 322 adenocarcinomas and 239 colorectal 
adenomas. Due to funding constraints, we restricted our genetic analyses to a random subset 
sample of 264 controls, 206 adenocarcinomas and 126 adenomas. Adenomas included into 
the analysis were large (!1 cm) without severe dysplasia, and with histopathological 
diagnosis of tubular, tubulovillous or villous adenoma (<20%, 20-80% and !80% of villous 
component, respectively). 
SNP Genotyping 
DNA was extracted from buffy coat samples, using the QIAamp DNA Blood Mini KIT 
(QIAGEN®), as recommended by the manufacturer and eluted in 100"l of Nuclease-free 
Water (Ambion®). Two hundred and fifty nanograms (250ng) of DNA were resuspended in 
5"l of TE Buffer, denatured and bound to paramagnetic beads for high-throughput 
genotyping using the protocols described for the highly multiplexed GoldenGate assay18 
(Illumina Inc.). Briefly, two allele-specific oligonucleotide (ASO) probes, linked to universal 
primer sequences (labeled with either Cy3 or Cy5 for each allele), along with one locus-
specific oligonucleotide (LSO) probe, also linked to a universal primer and an address 
sequence, are hybridized to the DNA. Extension of the ASO and ligation to the LSO is 
carried out and the product is amplified by PCR. The amplified product was hybridized to the 
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chips containing sequences complementary to each unique address sequence and the alleles 
were determined by the scanner according to the fluorescent emitted (Cy3, Cy5, or both). The 
SNP panel used for this study (Illumina Cancer Panel®) consist of 1,421 thoroughly screened 
and validated SNP loci, covering all chromosomes and tagging 408 genes chosen from the 
National Cancer Institute's (NCI) Cancer Genome Anatomy Project SNP500 Cancer 
Database19.  According to the manufacturer, the mean Minor Allele Frequency (MAF) across 
all the SNPs in the genotyping panel was 0.25, 0.22 and 0.21 for Caucasians, Han Chinese/ 
Japanese and Yoruba Africans respectively. 
 
Quality Control 
We followed a standard quality control (QC) protocol for case-control genetic association 
studies20 using the PLINK software21.  SNPs were excluded from the analysis if they departed 
from Hardy-Weinberg equilibrium (HWE; p<0.01), there was a significant difference 
between missing genotype rates among cases and controls (p <0.01), the SNP overall call rate 
was <0.95, or the MAF was <0.04.  Participants with call rates #0.95, or with heterozygosity 
rates >3 standard deviations from the sample mean, were also excluded. In addition, we 
excluded one individual of each pair featuring an Identity by Descendant value (IBD) >0.375 
from the analysis, avoiding duplicated, related or contaminated samples. Gender could not be 
reliably estimated from the limited number of SNPs available on the X chromosome (N =13), 
and we relayed on our recorded gender. Eighteen percent of the controls (n=21), 10% of the 
adenomas (n=13), 7.7% of adenocarcinomas (n=16), and 15.8% of the SNPs (n=225) did not 
pass through the quality control, leaving 238 controls,113 adenomas and 190 
adenocarcinomas for the analysis.  
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Inference of Ancestry Proportions 
We used the Bayesian clustering algorithm STRUCTURE version 2.222 under an admixture 
model to estimate the proportions of European, African and Amerindian ancestry in each of 
our samples. We used a flat prior to ran a burn-in period of 5000 iterations and kept 1 in 5000 
iterations. Under the admixture model, the genotype information of each individual is 
modeled assuming that they inherited a fraction of their genome from ancestors originating 
from one of the kth populations of origin.  We included a set of overlapping SNPs (N= 804) 
genotyped in three reference ancestral populations (k=3) from the HapMap3 project23: Utah 
residents with Northern and Western European ancestry (CEU), Luhya in Webuye, Kenya 
(LWK) and Han Chinese in Beijing, China (CHB). The well-established similarities of the 
allele frequencies between the  latter population and Amerindians24, made it a useful 
alternative to discriminate the Amerindian from African and European ancestry in the study 
sample. Six hundred seventy eight (678) autosomal SNPs remained for analysis after pruning 
for Linkage Disequilibrium (LD), excluding one of each pair with R2 higher than 0.5, in a 
windows size of 50 SNPs and a window shift of 5 SNPs. 
To verify the admixture estimations using the selected set of SNPs, we also estimated the 
ancestry fractions of individuals from two admixed populations included in the HapMap3 
database: Mexican ancestry from Los Angeles (MEX) and African ancestry in Southwest 
USA (ASW). Finally, we calculated the informativeness for assignment measure (In) 
proposed by Rosenberg et al.25 to estimate the ancestral information that each SNP included 
provides. 
 
Statistical Analysis 
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We compared the mean ancestry fractions between cases (adenomas and carcinomas) 
and controls using one way ANOVA tests. To evaluate the association of genetic ancestry 
with adenoma and cancer separately, we used binary conditional logistic regression models 
controlling for potential confounding factors. Because ancestry fractions are dependant from 
each other they can not be handled as independent variables. To overcome this limitation, 
without leaving out from the analysis any of the ancestry fractions we  include into the model 
two parameters: the arithmetic difference between  European and Amerindian ancestry 
fractions (main genetic substitution in Latin American populations) and the estimated African 
ancestry (log transformed). The latter was log transformed as it was positively skewed in the 
study population (Figure 1). These two parameters were fitted alternatively as raw continuous 
(to evaluate the linear trend) and categorical variable to measure the variation in risk per 10% 
increase of African ancestry (from 0.01 to !0.30) and European replacement increase (from 
#-0.30 to ! 0.30). We avoid the pairwise comparison of the resulting categories in the logistic 
regression analysis, but we report their distribution for descriptive purposes.26 The 
multivariate analysis, which had city of enrollment as conditional variable, included: gender, 
age, attained education level (none, elementary school, secondary school, technical studies 
(i.e. college), University or higher), family history of colorectal cancer in first-degree 
relatives, history of alcohol intake (no intake, <12.50 and !12.50 g/day); cigarette smoking 
(<0.5, 0.5-0.9 and !1 packs/year ); red meat consumption (< 2 , 2-4 and !5 servings per 
week);  physical activity (<10, 10-19, !20 hours per week), non-steroid anti-inflammatory 
drugs (at least one per week during the last 6 months, yes or no), dietary fiber and total 
energy intake (quartiles regarding the distribution among controls).  
Results  
Cases were slightly older than controls. While adenomas where positively associated with 
higher attained education (p=0.02), adenocancinomas showed the opposite, being positively 
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associated with lower educational level instead.(p<0.01) Cancer cases also showed an inverse 
association with BMI at diagnosis, probably due to reverse causation (Table 1).  No other 
differences were observed among the risk factors included into the analysis.  
Among adenomas cases, European (mean 0.44 CI95% 0.42-0.46) and African (mean 0.13 
CI95% 0.11-0.15) ancestry proportion were higher compared to controls (European mean 
0.39 CI95% 0.38-0.41; African mean 0.11 CI95% 0.10-0.12), while the Amerindian mean 
proportion behave just inversely proportional to the European. In contrast, cancer cases 
showed a higher mean proportion of African ancestry compared to controls (0.14 vs 0.11  
p<0.01) (Table 2). When comparing the categorical distribution of African ancestry and  
European ancestry substitution (European minus Amerindian ancestry fractuions) in the study 
population we observed similar results: an association of African ancestry with both 
adenomas (p=0.07) and cancer (p=0.02), while the European genetic substitution only was 
associated with adenoma (p=0.001) but not with cancer cases (p=0.95) (Table 3). Ancestry 
fractions estimated for the MEX and ASW population were very similar to those reported in 
the literature27 despite the low In values featured by the SNP included in our analysis  (max= 
0.34, mean=0.03, SD=0.04), reassuring the reliability of the ancestry estimations.  
After controlling for confounding, conditional logistic regression analysis results were 
consistent with the crude ones, showing a positive marginal association of increasing African 
ancestry with colorectal adenomas (risk variation per 10% increase [OR] 1.122 CI 95% [0.97, 
1.30] p for linear trend=0.08) and statistically significant with adenocarcinomas (risk 
variation per 10% increase [OR] :1.19 CI95%   [1.05 , 1.35], p for trend 0.003] (Table 4). In 
contrast, increasing European ancestry was positively associated only to adenoma (risk 
variation per 10% increase [OR] 1.25 CI95% [1.08,1.46] CI95% p for trend 0.001) but not to 
cancer (risk variation per 10% increase  [OR] 1.02 CI95%[0.90- 1.16], p for trend 0.75).  In 
addition, adenoma was associated with university or higher education compared to primary 
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school (the most prevalent category) (OR 3.81, 95%CI1.59 – 9.17), while colorectal cancer 
risk was marginally associated with no education attained (OR 2.5 95%CI 0.89 – 7.36). 
Adjusting by age and sex did not modify the results-significantly (Table 4). There was no 
evidence of heterogeneity in the mean differences of African ancestry when comparing 
adenomas or adenocarcinomas to controls across education strata (Figure 2). When exploring 
the ancestry association, stratified by distal and proximal colorectal neoplasms we did not 
observed any differences from the overall results (results not shown). 
 
Discussion   
To the best of our knowledge this is the first report on the association of genetic ancestry and 
sporadic colorectal adenomas and adenocarcinomas in an admixed population. Our findings 
add evidence to the hypothesis that genetic ancestry influences cancer risk in Latino 
populations. A similar positive association of genetic ancestry has been reported previously 
between European ancestry and breast cancer in the Mexican population28; In a clinical 
practice scenario genetic ancestry fractions has being proposed as a genome-wide biomarker 
useful to evaluate relapse in children undergoing therapy for acute lymphoblastic leukemia29. 
 The association of African ancestry not only with adenocarcinoma but also marginally 
with adenoma supports our hypothesis of the role of genetic ancestry in early stages of 
colorectal carcinogenesis and may rely on differences in allele frequencies in polymorphism 
related to colorectal cancer risk30. We found that this association was not confounded by 
well-known risk factors. Education was chosen as proxy of socioeconomic status (SES) as it 
is attained early in life and does not change greatly after the third decade of life.  SES has 
previously been associated independently to colorectal cancer worldwide and to genetic 
ancestry in Latin America. The nature of the association between SES and colorectal cancer 
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risk is discrepant across continents31. While studies in Europe, East Asia and Australia, in 
general, have found a positive association, in the US and Canada the association observed is 
inverse31,32. This discrepancy is not fully understood but it is partially explained by 
differences in screening coverage31 and the way environmental factors (mediators) are 
interrelated with SES (determinants)32,33. Our results are contrary to a previous study 
reporting a positive association of colorectal cancer and SES in Colombia34. Here we found 
an inverse association of education level with adenocarcinoma., but also a positive 
association on higher education level with adenoma (Table 4). This finding may explain 
partially the association of European ancestry only with adenomas; more than a third of 
adenomas cases showed European ancestry fraction within its higher category (Table 3). A 
previous report has shown the positive association on European ancestry with higher 
education among Latinos. 35 
  In contrast, the positive association of African ancestry to both adenoma and 
adenocarcinoma reported here is hard to explain due to differences in SES given that in our 
study: first,  African Ancestry was not associated with education level (p for trend = 0.76) 
(Figure 3) and second, adenomas and adenocarcinomas showed opposite association to 
education level. It is worth mentioning that Afro-Colombians are an ethnic minority with 
large disparities compared with the overall population. In our study population the African 
ancestry was not high (interquartile range 0.6- 0.24) as African-Americans (80%) and its 
likely that within this range most of the individuals did not identify themselves as being of 
African descent.  
Our study features several strengths. It includes both preneoplasic and neoplasic lesions 
confirmed by histopathology allowing us to evaluate the association of ancestry in the early 
events of colorectal carcinogenesis. We sampled cases and controls from the same 
population. As cases are mostly referred by general physicians this assures a better control for 
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selection bias. Our ancestry estimations are reliable as those estimated for the ASW and 
MEX individuals were similar to those  published in the literature27. The differences in the 
anatomic distribution of adenomatous polyps and cancer showing a shift to the left for cancer 
cases was observed as previously described36 and the similar age range in adenomas and 
adenocarcinomas does not suggest a selection bias37.  
There are some limitations of our study that should be considered when interpreting the 
results. It is likely that educational levels do not reflect, nor control, the entire variability of 
the socioeconomic status, thus residual confounding may exist. Nevertheless, here we 
assessed and included into the analysis the most relevant nutritional and lifestyle factors that 
may mediate the association of SES with colorectal adenoma and adenocarcinoma. There 
could be a differential access to colonoscopy, where wealthy people may have better access 
to these procedures. However, the chance of under representation of individuals with a higher 
level of education in the control group is not likely, as recent census data38 in Colombia 
showed that only 9% of the population have university or a higher education degree, a similar 
value observed in our control sample (11%). Our sample size provides limited statistical 
power to detect small effects, especially regarding the observed effect in the association 
between African ancestry and adenomas. Nevertheless, we reduced multiple hypothesis 
testing to the minimum. In addition,  the point estimates observed showed narrow confidence 
intervals and the crude and adjusted results were consistent. In addition, we would expect that 
if African ancestry is actually associated with colorectal cancer risk, it would also be 
associated with its main precursor lesion. However, the use of a common set of controls 
could also explain such association and therefore the results should be interpreted with 
caution. As an observational study, residual confounding cannot be ruled out. Replication of 
these results is warranted to validate our results. 
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The positive association of African genetic ancestry with adenoma and colorectal cancer is 
consistent with a recent publication reporting that colorectal cancer risk is likely to be 
mediated through genetic susceptibility to adenomas39. Early detection of adenomas is a key 
issue in colorectal cancer control. Newly published evidence supports that detecting 
adenomas and removing them, not only decreases the incidence, but also the mortality of 
colorectal cancer40. There is now promising evidence showing that genetic markers could 
discriminate population at increased risk of colorectal cancer.  It has been shown, for example  
that adding information of SNPs associated with colorectal cancer to family history increases 
the absolute risk estimation of having the disease at population level41.  
Further research should address how these SNPs, discovered mainly in European Caucasian 
population, influence the genetic association here reported. Admixture mapping42 could be 
the next step to further explore the mechanism behind this association. There is no admixture 
mapping analysis published so far on colorectal cancer despite the large number of GWAS on 
this cancer.  A variant in chromosome 8q24 initially described by admixture mapping for 
prostate cancer in African Americans, showed also a positive association with colorectal 
cancer risk30 and recently, a Case control study report an association of one 8q24 loci variant 
(rs380284) and adenoma risk in Caucasians39  
In conclusion, we report for the first time, that African ancestry (or variants linked to 
it) contributes to the susceptibility of colorectal cancer in admixed Latin American population 
Our  results are promising as may help get insights of colorectal carcinogenesis and even 
more to find biomarkers useful to stratify colorectal cancer risk  in the Latino populations, 
where colorectal mortality rates are increasing, although not high enough to recommend mass 
screening programs43. 
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LEGENDS TO FIGURES 
Figure 1. Quantile-Normal plot per ancestry fraction in the study population 
Figure 2.  Forest plot for the Standardized Mean Differences (SMD) of African Ancestry 
fraction (log scale) in Adenomas and Adenocarcinomas stratified by Education level 
attained.   
Figure 3.  European and African Ancestry Fraction Box plot per Education level attained in 
the study population 
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  Controls   Ademoma Adenocarcinoma 
Risk factor (n=243)   (n=113) 
p 
(n=190) 
p 
  n %   n % n % 
Sex                   
Female 141 58.02   54 47.79   90 47.4   
Male 102 41.98   59 52.21 0.13 100 52.6 0.14 
Age                   
mean y, (sd)   54.2 (0.76)     
57.4 
(0.94) 0.01   
57.9 
(12.3) 0.01 
Education Attained                   
None 6 2.5   2 1.8   18 9.5   
Primary School 91 37.4   33 29.2   75 39.5   
Secondary 89 36.6   37 32.7   61 32.1   
College 28 11.5   11 9.7   11 5.8   
University 29 11.9   30 26.5 0.02 25 13.2 <0.01 
Colorectal Cancer Family History       113           
No 231 95.0   104 92.0   176 92.6   
Yes 13 5.0   9 8.0 0.26 14 7.4 0.29 
Alcohol Intake (gr/ day)                   
No intake 135 55.6   72 63.7   107 56.3   
<12.5 70 28.8   22 19.5   49 25.8   
12.5 38 15.6   18 15.9 0.17 33 17.4 0.75 
Smoking (packs/y)                   
Non smoker 146 60.1   71 62.8   112 58.9   
less than  1 51 21.0   16 14.2   32 16.8   
1 46 18.9   26 23.0 0.35 45 23.7 0.27 
Red Meat  (servings p/w)                   
less than  2 42 17.3   20 18.6   35 18.4   
2-5 121 49.8   51 44.2   80 42.1   
5 78 32.1   34 30.1 0.83 62 32.6 0.59 
Energy Intake (Quartile)                   
Q1 60 24.7   30 26.5   29 15.3   
Q2 61 25.1   29 25.7   41 21.6   
Q3 61 25.1   19 16.8   50 26.3   
Q4 60 24.7   25 22.1 0.53 56 29.5 0.13 
BMI                   
<20 6 2.5   5 4.4   35 18.4   
20-24 85 35.0   36 31.9   82 43.2   
25-29 111 45.7   47 41.6   47 24.7   
30 45 18.5   23 20.4   24 12.6 <0.01 
NSAID                   
No 184 75.7   87 77.0   148 77.9   
Yes 59 24.3   26 23.0 0.84 42 22.1 0.6 
Dietary Fiber (Quartile)                   
Q1 61 25.1   24 21.2   44 23.2   
Q2 61 25.1   23 20.4   39 20.5   
Q3 61 25.1   25 22.1   48 25.3   
Q4 59 24.3   33 29.2 0.63 46 24.2 0.88 
Physical Activity (ipaq categories)                   
Low 102 42.0   58 51.3   77 40.5   
Moderate 72 29.6   27 23.9   49 25.8   
High 69 28.4   28 24.8 0.17 64 33.7 0.6 
City of enrolment                   
Bucaramanga 69 28.4   35 31.0   40 21.1   
Bogota 30 12.3   10 8.8   23 12.1   
Cartagena 33 13.6   12 10.6   26 13.7   
Cali 33 13.6   10 8.8   33 17.4   
SantaMarta 26 10.7   20 17.7   27 14.2   
Barranquilla 52 21.4   26 23.0 0.51 41 21.6 0.56 
Anatomic location                   
Colon NOS       8 7.1   8 4.2   
Right Colon       40 35.4   48 25.3   
Left Colon       43 38.1   42 22.1   
Rectum       22 19.5   92 48.4   
 
Table2. Mean ancestry fraction and 95% Confidence intervals in controls, 
adenomas, adenocarcinomas and admixed population (MEX  and ASW) included 
into the analysis( 
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Table3.  Categorical Distribution of African and European Ancestry 
Substitution * in controls, adenomas and Colorectal cancer cases, included 
into the analysis. 
  Control Adenomas Cancer 
  n n n 
  % % % 
African Ancestry       
0.01 - 0.09 110 39 58 
  45.27 34.51 30.53 
        
0.10- 0.19 58 38 64 
  23.87 33.63 33.68 
        
0.20 - 0.29 39 24 34 
  16.05 21.24 17.89 
        
0.30 - 0.39 36 12 34 
  14.81 10.62 17.89 
p value+   0.07 0.02 
        
European Ancestry*       
" -0.30 55 12 46 
  22.63 10.62 24.21 
        
-0.29   -  -0.20 40 17 34 
  16.46 15.04 17.89 
        
-0.19 -  -0.10 49 20 39 
  20.16 17.7 20.53 
        
0 - 0,09 58 22 36 
  23.87 19.47 18.95 
        
0.10- 0.19 41 42 35 
  16.87 37.17 18.42 
p value+   0.001 0.87 
*European Ancestry corrected for Amerindian Ancestry (European Fraction minus 
Amerindian Ancestry) 
+ p value for chi squared test.  
Table 4.  Odds Ratio (OR) and 95% Confidence intervals (CI) of Age and Sex 
Adjusted and fully adjusted conditional regression models for Genetic ancestry 
fractions and known risk factor of colorectal adenoma and adenocarcinoma. 
Characteristic
OR 95% CI ! OR 95% CI p
Age-Sex adjusted model
African Ancestry
risk variation per 10% increase 1.13 [0.99,1.27] !"!# 1.18 [1.06,1.31] 0.001
p for trend 0.09 0.002
European Ancestry
risk variation per 10% increase 1.25 [1.08,1.46] !"!!$ 0.98 [0.88,1.10] 0.79
p for trend 0.0004 0.91
Full Adjusted model
African Ancestry ref - ref -
risk variation per 10% increase 1.12 [0.97,1.30] !"$% 1.19 [1.05,1.35] 0.006
p for trend 0.08 0.003
European Ancestry
risk variation per 10% increase 1.25 [1.08,1.46] !"!!& 1.02 [0.90,1.16] 0.75
p for trend 0.001 0.68
Education Attained None 0.77 [0.11,5.24] !"#$ 2.56 [0.89,7.36] 0.08
Primary School ref - ref -
Secundary 1.5 [0.74,3.06] !"%& 0.77 [0.45,1.30] 0.4
College 2.11 [0.78,5.75] !"'( 0.55 [0.23,1.31] 0.23
University 3.82 [1.59,9.17] !"!' 1.03 [0.60,2.52] 0.95
Colorectal Cancer Family 
History*
yes 1.73 [0,60,5.02] !")* 1.72 [0.67, 4.40] 0.74
Alcohol Intake (gr/ day)* <12.5 0.65 [0.30,1.44] !"%$ 1.08 [0.56,2.07] 0.82
12.5 0.86 [0.40,1.83] !"&$ 0.97 [0.48,1.94] 0.92
Smoking (packs/y) <0.5 ref - ref -
0.5-0.9 0.65 [0.30,1.44] !"%$ 1.08 [0.56,2.07] 0.82
1 0.86 [0.40,1.83] !"&$ 0.97 [0.48,1.94] 0.92
Read Meat      (times p/w) <2 ref - ref -
2-4 0.87 [0.41,1.84] !"#' 1.34 [0.67,2.67] 0.41
5 0.84 [0.37,1.88] !"&# 1.66 [0.80,3.42] 0.17
Energy Intake (Quartile) Q1 ref - ref -
Q2 0.81 [0.35,1.88] !"&% 0.64 [0.31,1.33] 0.23
Q3 1.21 [0.49,2.99] !"&$ 0.68 [0.30,1.52] 0.34
Q4 1.36 [0.51,3.65] !"+( 0.44 [0.18,1.08] 0.09
NSAID Yes 0.6 [0.29,1.21] !"'+ 0.93 [0.52,1.66] 0.82
Dietary Fiber (Quartile) Q1 1
Q2 0.81 [0.35,1.88] !"&% 0.64 [0.31,1.33] 0.23
Q3 1.21 [0.49,2.99] !"&$ 0.68 [0.30,1.52] 0.34
Q4 1.36 [0.51,3.65] !"+( 0.44 [0.18,1.08] 0.07
Physical Activity (ipaq 
categories)
Low
Moderate 0.67 [0.34,1.32] !"'( 0.77 [0.43,1.37] 0.37
High 0.76 [0.37,1.54] !"(( 0.89 [0.50,1.60] 0.7
!‡  European ancestry  substitution effect (European - Amerindian ancestry)  adjusted only for age, sex and city of enrollment
! European ancestry  substitution effect (European - Amerindian ancestry) adjusted for age, sex, city of enrollment 
and all other factors listed
*Absence of the exposure considered as reference value
Adenoma Adenocarcinoma
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